Satisfying varied demand with the capability to produce a full range of desired tracers on one system and the functionality to develop new tracers.
FASTlab 2 has three levels of licensing enabling you to access the range of tracers you desire:
• FASTlab 2 Multi–Tracer – GMP production of key tracers
• FASTlab 2 Tracer–Alliance – Access to new tracers developed by partners
• FASTlab 2 Developer (b) – Develop and produce your own tracers
FASTlab 2 Tracer-Alliance
Use additional tracer applications from third party vendors (Note 3).
Share and produce tracers that have been developed using FASTlab 2 Developer with multiple sites – facilitating multi-center studies and pharmaceutical trials.
Note 1: Tracer-Alliance license includes Multi-Tracer license. Developer license includes Tracer-Alliance and Multi-Tracer licenses.
Note 2: Customers should gain US Food and Drug Administration (FDA) approval for their tracers. FDA approval has been given for FDG and NaF tracers. Outside US approval depends on local regulation. FMISO and FLT are investigational agents not yet approved by regulatory authorities.
(b) Special terms and conditions apply for FASTlab 2 Developer
Note 3: GE Healthcare has no liability for third-party products. GE Healthcare is not responsible for the availability of these tracer applications.